United in Compassion (UIC) has added a regulatory compliance training session to its Australian Medicinal Cannabis Symposium 2025 program and extended early-bird sales until October 15.
Featuring legal and regulatory experts including Australian Medicinal Cannabis Association (AMCA) chair Dr Teresa Nicoletti and Enimera RegsPlus director and consultant Dr Mary Nteris, the session will provide a comprehensive overview of the key aspects of compliance including:
- The implications of medicinal cannabis being a registered medicine in Australia.
- How to comply with advertising regulations for scheduled medicines.
- The implications of recent disciplinary action and how to avoid it.
The symposium, which takes place during Medicinal Cannabis Awareness Week 2025 at Brisbane’s Royal International Convention Centre from February 21-23, will focus on ‘Optimising Quality and Compliance’ and feature tailored programs for prescribers, nurses, pharmacists and cultivators.
The Therapeutic Goods Administration and Office of Drug Control have both committed to attend, while a ‘50 shades of green’ themed party will be held at the Tivoli Theatre on the Saturday night.
Discussions over the three days include:
- Does cannabis cause psychosis?
- Cannabis use in the elderly and why this demographic is growing so quickly.
- Safe prescribing guidelines for high-THC medicine.
- Cannabis use in the veteran and first responder populations.
- Cannabis prescribing for paediatric populations.
- Cannabis use and the opioid crisis. Can it help? How much? How?
For more information and to book, click here.
